SEBI Circular, Notification, provisions Take over code Listing norms Corporate laws Listed Companies FII investments Stock brokers BSE NSE Mutual Funds IPO News
SEBI : Failure to comply with accounting standards may violate LODR regulations, affecting financial transparency, director accountabilit...
SEBI : SEBI’s LODR Amendments 2024 introduce key changes in compliance, RPTs, and governance. Are they simplifying processes or adding ...
SEBI : Learn the common reasons for DRHP rejection, including incomplete disclosures and non-compliance, and practical measures to naviga...
SEBI : Understand compliance requirements for listed companies under SEBI LODR 2015, including ESG, BRSR Core, and market cap-based oblig...
SEBI : Explore India's move to T+0 equity settlement, offering same-day trade finalization. Learn about its benefits, challenges, and imp...
SEBI : SEBI proposes changes to disclosure norms for REITs and InvITs. Public comments are invited until March 7, 2025. Submit feedback v...
SEBI : SEBI invites public comments on strengthening ESG Rating Providers. Feedback can be submitted online by March 6, 2025. Read the co...
SEBI : SEBI drafts new rules for margin pledges to prevent misuse of client securities and seeks public comments by March 4, 2025....
SEBI : SEBI invites comments on revising advance fee limits for Investment Advisers and Research Analysts, proposing a one-year cap with ...
SEBI : SEBI proposes a mechanism to manage unclaimed client funds and securities with Trading Members. Public comments invited until Marc...
SEBI : SEBI prosecutes directors of Gujarat Arth Ltd for market manipulation and fraudulent trading under SEBI Act....
SEBI : Since 1986 to 1997, Petitioner acquired shares, in tranches, of Respondent No.4-Company. The Petitioner subsequently sold some of ...
SEBI : In the instant case, assessee was a senior citizen and a medical practitioner, had his Demat accounts frozen by the National Secur...
SEBI : Explore the disclosure and compliance requirements for listed entities under SEBI regulations, including quarterly, half-yearly, a...
SEBI : Supreme Court's landmark ruling in SEBI v. Abhijit Ranjan clarifies insider trading laws, emphasizing the importance of profit mot...
SEBI : SEBI relaxes deadlines for Alternative Investment Funds (AIFs) to hold investments in dematerialised form, with new requirements e...
SEBI : SEBI updates Consolidated Account Statement (CAS) timelines, extending data submission and dispatch deadlines for monthly and half...
SEBI : Learn about SEBI’s Industry Standards Manual, outlining the formation, scope, and functioning of Industry Standards Forums to ea...
SEBI : SEBI introduces MITRA, a platform to help investors trace inactive and unclaimed Mutual Fund folios, ensuring transparency and fra...
SEBI : SEBI issues guidelines for stock brokers to access NDS-OM for Government Securities trading under Separate Business Units. Complia...
SEBI allows simplified registration for FPIs by introducing an abridged Common Application Form, reducing duplication for eligible applicants.
SEBI invites public comments on the procedure for seeking a waiver or reduction of interest on penalty recovery proceedings by Dec 2, 2024.
SEBI issues updated Master Circular for ICDR Regulations, consolidating directions till September 30, 2024, with a chapter-wise compliance framework.
SEBI issues updated Master Circular for LODR Regulations, consolidating compliance provisions for listed entities, stock exchanges, and other stakeholders.
SEBI outlines the procedure for reclassifying FPI investments to FDI for holdings exceeding 10% in Indian companies, effective immediately.
SEBI mandates brokers offer trading supported by blocked funds, including UPI block or 3-in-1 trading accounts, starting February 2025.
SEBI seeks public comments on revising the UPSI definition under Insider Trading Regulations for better clarity and compliance. Deadline: November 30, 2024.
SEBI denies Glenmark Life Sciences’ request for no-action relief, stating contra trade restrictions apply to its proposed share sale for minimum public shareholding compliance.
SEBI states sale to meet public shareholding norms isn’t exempt from insider trading rules, impacting Nirma’s share sale in Glenmark Life Sciences.
SEBI provides informal guidance to CMS Info Systems on promoter disclosures and nominee shareholder roles under LODR and ICDR regulations.
